These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28688023)

  • 1. [PET-CT and PET-MRI of the prostate : From
    Knorr K; Eiber M; Maurer T; Wester HJ; Scheidhauer K
    Radiologe; 2017 Aug; 57(8):631-636. PubMed ID: 28688023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent prostate cancer: combined role for MRI and PSMA-PET in
    Jannusch K; Bruckmann NM; Morawitz J; Boschheidgen M; Quick HH; Herrmann K; Fendler WP; Umutlu L; Stuschke M; Hadaschik B; Antoch G; Schimmöller L; Kirchner J
    Eur Radiol; 2024 Jul; 34(7):4789-4800. PubMed ID: 38038758
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions.
    Scobioala S; Kittel C; Wolters H; Huss S; Elsayad K; Seifert R; Stegger L; Weckesser M; Haverkamp U; Eich HT; Rahbar K
    Ann Nucl Med; 2021 May; 35(5):628-638. PubMed ID: 33742373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Body Integrated [
    Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
    Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
    Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of
    Kranzbühler B; Nagel H; Becker AS; Müller J; Huellner M; Stolzmann P; Muehlematter U; Guckenberger M; Kaufmann PA; Eberli D; Burger IA
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):20-30. PubMed ID: 29032394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid PET/MRI in major cancers: a scoping review.
    Morsing A; Hildebrandt MG; Vilstrup MH; Wallenius SE; Gerke O; Petersen H; Johansen A; Andersen TL; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2138-2151. PubMed ID: 31267161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of molecular imaging (PET-CT) in the diagnostic and treatment pf prostate cancer].
    Mirzaei S; Knoll P; Zandieh S
    Wien Med Wochenschr; 2019 Feb; 169(1-2):12-14. PubMed ID: 30349972
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Malaspina S; De Giorgi U; Kemppainen J; Del Sole A; Paganelli G
    Radiol Med; 2018 Dec; 123(12):952-965. PubMed ID: 30116970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual comparison between
    Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of
    Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM
    Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
    Kulkarni SC; Sundaram PS; Padma S
    Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and localisation of primary prostate cancer using
    Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M
    BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in
    Freitag MT; Radtke JP; Afshar-Oromieh A; Roethke MC; Hadaschik BA; Gleave M; Bonekamp D; Kopka K; Eder M; Heusser T; Kachelriess M; Wieczorek K; Sachpekidis C; Flechsig P; Giesel F; Hohenfellner M; Haberkorn U; Schlemmer HP; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):776-787. PubMed ID: 27988802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
    Tulsyan S; Das CJ; Tripathi M; Seth A; Kumar R; Bal C
    Nucl Med Commun; 2017 Dec; 38(12):1094-1102. PubMed ID: 28957842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.